BioCentury
ARTICLE | Company News

Athersys, DDDP in GPCR deal

October 29, 2001 8:00 AM UTC

Athersys (Cleveland, Ohio) and 3-Dimensional (DDDP) partnered to discover, develop and market small molecule compounds screened against GPCR targets. Athersys will use its RAGE (Random Activation of G...